Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abiomed Inc (NQ: ABMD )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 21, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abiomed Inc

< Previous 1 2 3 Next >
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Gainers 
Via Benzinga
FDA Approves Abiomed's Impella Low Profile Sheath
Via Benzinga
Abiomed's Impella Shows Heart Function, Symptom Improvements For High-Risk PCI Patients
Via Benzinga
Abiomed: Q1 Earnings Insights
  Abiomed (NASDAQ:ABMD) reported its Q1 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: Abiomed Q4 Earnings
Abiomed (NASDAQ:ABMD) reported its Q4 earnings results on Thursday, April 28, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Gartner, Sony, Uber And Other Big Gainers From Tuesday
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Why Abiomed Stock Skyrocketed Today
A healthcare titan wants to acquire the medical technology specialist for a whopping $16.6 billion. 
Via The Motley Fool
What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal
As the exodus out of mega-cap technology stocks continues, investors and money managers are looking for other sectors to rotate into. 
Via Benzinga
10 Best Stocks to Buy Now in November
These beaten-down growth stocks have significant upside. 
Via The Motley Fool
What 4 Analyst Ratings Have To Say About Abiomed
Abiomed (NASDAQ:ABMD) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 70 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Investors Wary Of Potential Fed Response To Resilient Labor Market
Stocks are pulling back from their morning gains, following data that showed U.S. job openings rose to 10.7 million in September. 
Via Talk Markets
Dow Drops Over 200 Points; Crude Oil Rises Sharply
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday. 
Via Benzinga
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads. 
Via Benzinga
Why Is Uber Stock Up Today?
Uber (UBER) stock is on the move Tuesday as investors react to results from the company's earnings report for the third quarter of 2022. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
US Stocks Trade Lower Ahead Of Fed Meeting; Pfizer Earnings Top Views
U.S. stocks traded lower this morning, with the Dow Jones dropping around 80 points on Tuesday. 
Via Benzinga
Why Is Carvana (CVNA) Stock Up 15% Today?
Carvana (CVNA) stock is climbing higher on Tuesday after JPMorgan analyst Rajat Gupta upgraded the company's shares to neutral. 
Via InvestorPlace
Why Is Abiomed (ABMD) Stock Up 50% Today?
Abiomed will become part of Johnson & Johnson's huge medical devices unit after being bought for $16.6 billion in cash. 
Via InvestorPlace
Johnson & Johnson Expands Cardiovascular Portfolio, Bets $16B In Abiomed's Heart Failure Devices
Via Benzinga
Uber Rides Higher, but Here's Tuesday's Big Stock Winner
Earnings are only part of the story. 
Via The Motley Fool
Recap: Abiomed Q2 Earnings
Abiomed (NASDAQ:ABMD) reported its Q2 earnings results on Tuesday, November 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Abiomed beat estimated earnings by... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning! 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
Upgrades 
Via Benzinga
Quant Ratings Updated on 97 Stocks
Over the weekend, I revised my Portfolio Grader recommendations for 97 blue-chip stocks, and many of them were in the tech industry 
Via InvestorPlace
Quant Ratings Updated on 85 Stocks
In today’s Market360, I have included a list of 10 stocks that were upgraded from a Hold to a Buy over the holiday weekend. 
Via InvestorPlace
A Preview Of Abiomed's Earnings
Abiomed (NASDAQ:ABMD) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that Abiomed will report... 
Via Benzinga
Markets Rise Despite Another New 2-Year High For US 10-Year Treasury Note
U.S. indices traded higher Tuesday on continued volatility as traders assess Fed policy outlook, rising Treasury yields and quarterly earnings reports. Investors continued to... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Upgrades 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback